Boston Scientific Invests $1.5 Billion in MiRus with Option to Buy ...

Boston Scientific invests $1.5B in MiRus heart valve startup

The deal gives Boston Scientific a 34% stake in MiRus and an option to buy its TAVR business for an additional $3 billion

Boston Scientific returns to heart-valve market with $1.5B investment in startup

Boston Scientific invests $1.5 billion in MiRus with option to buy ...

Boston Scientific invests $1.5bn for equity stake in MiRus

Boston Scientific has announced a $1.5bn investment to acquire a 34% equity stake in implants and procedural solutions developer MiRus.The post Boston Scientific invests $1.5bn for equity stake in MiRus appeared first on Hospital Management.

Boston Scientific invests $1.5B in MiRus with option to buy its TAVR business

Boston Scientific has invested heavily in Georgia-based MiRus, a rising name in the competitive TAVR landscape.

Boston Scientific's $1.5B nickel-free heart valve deal with $3B option

Deal adds a $3B path to full MiRus TAVR ownership after milestones, on top of Boston Scientific's $1.5B stake in a nickel-free valve for severe aortic stenosis.